East Asia

East Asia spans countries including China, Japan, South Korea, and Taiwan. This archive gathers reported milestones from the region — covering public health, environmental efforts, technology, and social progress. Each entry highlights specific, verifiable developments worth knowing about.

Seoul at night, for article on South Korea same-sex health insurance

South Korea court recognizes same-sex couple rights for first time

Same-sex health insurance benefits just won recognition in a South Korean court for the first time, in a case brought by So Seong-wook after the national insurer reversed his approved coverage as his partner’s dependent. The Seoul High Court ruled that denying spousal benefits to a same-sex couple was unlawful discrimination, with judges writing that being in the minority “cannot be wrong itself.” The decision doesn’t legalize same-sex marriage, but it reads existing law broadly enough to include same-sex partners in one of the most practical recognitions a state offers. In a country still without a legal framework for same-sex partnerships, that’s a meaningful crack in the wall — and a reminder that equality often arrives one plaintiff, one ruling at a time.

Aerial view of Shanghai traffic, for article on global EV sales

10% of global car sales were electric in 2022 for first time ever

Electric vehicles crossed a quiet but enormous threshold in 2022, making up one in every ten new cars sold worldwide for the first time. Roughly 7.8 million fully electric vehicles found buyers that year, even as overall car sales slipped. China led the charge, with EVs accounting for nearly a fifth of new cars sold there, while Europe wasn’t far behind at 11%. Behind the numbers is a deeper shift: battery prices have fallen dramatically over the past decade, and major automakers are doubling their EV output even as their broader sales decline. Ten percent is the moment a technology stops being niche and starts reshaping an industry — a hopeful signal for the global push toward cleaner transport.

DNA, for article on artificial DNA cancer

In a world first, Japenese scientists use artificial DNA to kill cancer cells

Artificial DNA that turns cancer’s own biology against itself marks a genuine conceptual leap in oncology. Japanese researchers at the University of Tokyo engineered synthetic molecules that lie dormant until they detect a chemical cancer cells overproduce — then restructure themselves into a signal the immune system reads as a threat, destroying the tumor from within. Early tests spanned multiple cancer types, suggesting broad potential. This kind of precision — working with the body’s existing defenses rather than overwhelming them — is exactly the direction cancer medicine has been reaching toward, and this research moves that goal meaningfully closer.

China compressed air energy storage, for article on compressed air energy storage

China turns on the world’s largest and most efficient compressed air energy storage plant

Clean energy storage just took a major leap forward, and it happened without a single fossil fuel involved. China’s new compressed air facility in Zhangjiakou runs entirely on thermodynamic processes, storing up to 400 MWh and operating at 70.4% efficiency — well above the 40–52% typical of existing systems. That’s enough to supply more than 132 GWh to the local grid annually, while avoiding roughly 109,000 tons of CO₂ each year. Proving that utility-scale, non-lithium storage can work commercially gives the global clean energy transition a powerful new tool to build on.

Injecting vaccine, for article on India HPV vaccine

Indian company develops country’s first HPV vaccine

CERVAVAC, India’s first homegrown cervical cancer vaccine, is priced at just $2.50 to $5.00 per dose — a fraction of what HPV vaccines have cost in wealthy countries for nearly two decades. Developed by the Serum Institute of India, it protects against the HPV strains responsible for the majority of cervical cancers worldwide, and the company aims to produce around 200 million doses in its first two years. Cervical cancer is almost entirely preventable, yet it still kills hundreds of thousands of women each year, mostly in lower-income countries where vaccines have been priced out of reach. An affordable, locally made option doesn’t just change the math for India — it points toward a future where health tools belong to the people who need them most.